Sujal M. Patel, CEO, President, and Secretary at Nautilus Biotechnology, Inc. (NAUT), bought 54,380 shares at $2.89 ($154K) on 2024-03-07, disclosed to the SEC on 2024-03-07.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.65 | 7,405 | $20K | 12.8% |
| 2 | $2.70 | 9,267 | $25K | 16.3% |
| 3 | $2.89 | 18,854 | $54K | 35.5% |
| 4 | $2.89 | 18,854 | $54K | 35.5% |
| Total | $2.82 avg | 54,380 | $154K | 100% |
| Filing → |
| NAUT | BUY | 2025-03-21 | $77K | — | Filing → |
| NAUT | BUY | 2024-03-11 | $41K | — | Filing → |
| NAUT | BUY | 2022-08-08 | $268K | — | Filing → |